Trials / Completed
CompletedNCT01341171
The Impact of Tamoxifen and Aromatase Inhibitors on Platelet Proteins
Platelet Modulation in the Control of Angiogenesis: The Impact of Tamoxifen and Aromatase Inhibitors on Platelet Activation and Angiogenic Proteins
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- University of Vermont · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Single phlebotomy study involving women receiving tamoxifen or aromatase inhibitor therapy.
Conditions
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2018-10-01
- Completion
- 2018-10-01
- First posted
- 2011-04-25
- Last updated
- 2020-09-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01341171. Inclusion in this directory is not an endorsement.